Justera Health Ltd C.VTAL

Marshall interview

[CandyC]

https://youtu.be/je-sTb6QlcQ

[OHSTweeter]

Did anyone else catch the DM CEO (Marshall Gunter) say, "There is an end to the Covid business, we all know that"? First, I think this business will be here to stay, unfortunately, if not for Covid-19 for the next hit illness. Second, what is he trying to say about ScreenPro, their "partner"? IMO, Marshall's bold statement really shows his lack of maturity in the CEO role.

[mellocello]

This post has been removed in accordance with Community Policy

[JWING17]

Well, Your thoughts are flawed, Go listen to it again.....And I would suggest YOU are the dummy. Just my thoughts.

[OHSTweeter]

I'm with you, I hope I'm wrong on Marshall's intentions on that statement. However, if it wasn't for Agoracom's specific request for clarificationnon that exact statement, he woild have looked have been stuck with it. I'm guessing the ScreenPro split wasn't as amicable as advertised. Either way, I'm hard on scrn, not dm, no forgive menif I get protective; I do know

[bohemian62]

Gunter may have chosen the wrong words to express his opinion but I respectfully disagree about him being a dummy . DM transitioning to telemedicine will utilize the AI however there still needs to be a treatment as end result and that will fall on SCRN . The emergence of corona viruses will only accelerate . CEO John McMullen is at work developing other revenue verticals to establish SCRN

[OHSTweeter]

Nice find! Thanks for that. Let's hope the market makers also agree. I just wanted to address the elephant in the room, instead of being so googly-eyed at financials. If we want to make money on this, we have to ask those tough questions and address those tough issues. I'm behind scrn, but let's hope Management feels that from us and can finally make something of themselves with this

[CriticalMind55]

OHSTweeter, from what I am deciphering from your resent posts, you are short pretending to be long, but I do not expect you to admit it...

[Resilience19]

@Critical, I agree with your comment, however, given SCRN markets itself as a COVID screening business, it's somewhat hard to project beyond the next 6 months, at this time. Granted, testing is likely to carry on for some time - especially given the impact of variants and unknown impacts on immunized populations - but it's difficult to define until when. When investing, it's

[bohemian62]

The revenue is actually accelerating and according to Gunter's comment it will not be letting up anytime soon . https://youtu.be/je-sTb6QlcQ?t=472

[silver(88)]

Love it! Thanks for the share. I agree. IMO this stock will seem to spike "out of nowhere," but those who have done their DD know what's coming. Cheers!

[OHSTweeter]

@Resilience19 a much more educated and unemotional response from you. Thank you. You and I are on the same page. Why invest in a lemonade stand when the market only sees 3 months of summer? Thus, now that we know scrn can create great revenue during Covid, Management must now prove to the market (and us the Shareholders) that the market will be thirsty for years to come (in whatever scrn does